Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00803868 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
A Phase 2 study, sponsored by University of South Florida.
- Terminated
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
NCT00803868 is a Phase 2 study that was terminated before completion, run by University of South Florida. The registered enrollment target is 28 participants.
The verdict
NCT00803868, a Phase 2 study, was terminated before completion, sponsored by University of South Florida.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if varenicline is effective in treating symptoms of Friedreich's ataxia.
Interventions
- DRUG placebo
- DRUG varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2009-05 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00803868
The ClinicalTrials.gov registry entry for NCT00803868 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00803868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00803868 about?
NCT00803868 is a clinical study titled "Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia". The purpose of this study is to determine if varenicline is effective in treating symptoms of Friedreich's ataxia.
What is the current status of trial NCT00803868?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2009-05. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00803868?
The interventions under investigation include: placebo (DRUG), varenicline (DRUG).
Who is sponsoring clinical trial NCT00803868?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.